| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 1,154,964 | 1,187,940 | 883,015 | 849,924 | | Cost of Revenue | 948,600 | 967,815 | 710,859 | 688,668 | | | Gross Profit | 206,364 | 220,125 | 172,156 | 161,256 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 131,013 | 132,358 | 125,325 | 119,022 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 18,527 | 17,951 | 17,369 | 17,169 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 56,824 | 69,816 | 29,462 | 25,065 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 51,413 | 69,816 | 29,462 | 25,065 | | Interest Expense | (2,704) | 2,704 | 2,892 | 2,757 | | Income Before Tax | 54,117 | 67,112 | 26,570 | 22,308 | | Income Tax Expense | 20,525 | 22,919 | 10,997 | 8,284 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 33,592 | 44,193 | 15,573 | 14,024 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (18) | (3) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,592 | 44,193 | 15,555 | 14,021 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $33,592 | $44,193 | $15,555 | $14,021 |
|
0.02% Nasdaq 0.00%
Income Statement
